These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 6928050

  • 1. Specific tumor immunity induced with mitomycin C-treated syngeneic tumor cells (MCT). Effects of carrageenan and trypan blue on MCT-induced immunity in mice.
    Wu RL, Kearney R.
    J Natl Cancer Inst; 1980 Jan; 64(1):81-7. PubMed ID: 6928050
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of immunological eradication of a syngeneic guinea pig tumor: participation of a component(s) of recipient origin in the expression of systemic adoptive immunity.
    Shu S, Fonseca LS, Kato H, Zbar B.
    Cancer Res; 1983 Jun; 43(6):2637-43. PubMed ID: 6342756
    [Abstract] [Full Text] [Related]

  • 3. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
    Bernstein ID.
    J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
    [Abstract] [Full Text] [Related]

  • 4. Eradication of a disseminated syngeneic mouse lymphoma by systemic adoptive transfer of immune lymphocytes and its dependence upon a host component(s).
    Mulé JJ, Rosenstein M, Shu S, Rosenberg SA.
    Cancer Res; 1985 Feb; 45(2):526-31. PubMed ID: 3881168
    [Abstract] [Full Text] [Related]

  • 5. Effects of carrageenan, PVP and tumour-bearer serum on immunity induced by excision or mitomycin C-treated tumour cells in mice.
    Kearney R, Wu RL, Orr F.
    Br J Cancer; 1979 Jun; 39(6):648-58. PubMed ID: 444404
    [Abstract] [Full Text] [Related]

  • 6. Immunity to lymphoid tumors in syngeneic mice by immunization with mitomycin C-treated cells.
    Benjamini E, Fong S, Erickson C, Leung CY, Rennick D, Scibienski RJ.
    J Immunol; 1977 Feb; 118(2):685-93. PubMed ID: 839074
    [Abstract] [Full Text] [Related]

  • 7. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T, Himeno K, Mitani M, Mori K, Miake S, Nomoto K.
    J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
    [Abstract] [Full Text] [Related]

  • 8. Modulation of anti-tumour immunity and the effect of bacterial endotoxin on the growth of different syngeneic tumours from small inocula in mice.
    Kearney R, Harrop P.
    Br J Exp Pathol; 1986 Jun; 67(3):371-81. PubMed ID: 3521708
    [Abstract] [Full Text] [Related]

  • 9. Immune responses to soluble tumor antigens in various stages of tumor growth.
    Brannen GE, Santos GW.
    Invest Urol; 1975 Sep; 13(2):79-84. PubMed ID: 1184342
    [Abstract] [Full Text] [Related]

  • 10. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B, Manohar V, Sugimoto T, Ashley MP, Kato Y, Rappaport P.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [Abstract] [Full Text] [Related]

  • 11. Immunogenic variants of a murine fibrosarcoma induced by mutagenesis: requirement of viable cells for antigen-specific cross-protection.
    LeGrue SJ, Simcik WJ, Frost P.
    Cancer Res; 1987 Aug 15; 47(16):4413-6. PubMed ID: 3607772
    [Abstract] [Full Text] [Related]

  • 12. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A, Simmons RL.
    Cancer Res; 1972 Jan 15; 32(1):16-21. PubMed ID: 4550256
    [No Abstract] [Full Text] [Related]

  • 13. Immune response to inactivated syngeneic mammary adenocarcinoma cells. I. Role and regulation of antibody synthesis in DBA/2 mice.
    DeLustro F, Haskill JS.
    J Natl Cancer Inst; 1980 Jan 15; 64(1):125-30. PubMed ID: 6928037
    [Abstract] [Full Text] [Related]

  • 14. T-cell-mediated antitumor immune response induced by oncofetal antigens.
    Gautam S, Deodhar SD.
    J Natl Cancer Inst; 1981 Oct 15; 67(4):939-45. PubMed ID: 6974275
    [Abstract] [Full Text] [Related]

  • 15. [Current topics on tumor immunology].
    Tachibana T.
    Gan No Rinsho; 1983 Oct 15; 29(13):1492-8. PubMed ID: 6608013
    [Abstract] [Full Text] [Related]

  • 16. In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents.
    Kataoka T, Oh-hashi F, Sakurai Y, Gomi K.
    Cancer Res; 1980 Oct 15; 40(10):3832-8. PubMed ID: 6254642
    [Abstract] [Full Text] [Related]

  • 17. Nonspecific Immunotherapy of Murine Solid Tumors With Corynebacterium granulosum.
    Milas L, Hunter B, Mason K, Grdina D, Withers H.
    J Natl Cancer Inst; 1975 Apr 15; 54(4):895-902. PubMed ID: 1127718
    [Abstract] [Full Text] [Related]

  • 18. Effect of carrageenan on the non-specific resistance of mice to injected syngeneic tumour cells, alone or in mixtures.
    Wu RL, Kearney R.
    Br J Cancer; 1979 Mar 15; 39(3):241-6. PubMed ID: 465296
    [Abstract] [Full Text] [Related]

  • 19. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
    Ujiie T.
    Jpn J Cancer Res; 1987 Jul 15; 78(7):737-47. PubMed ID: 3114200
    [Abstract] [Full Text] [Related]

  • 20. Effector mechanism in concomitant immunity potentiated by intratumoral injection of Nocardia rubra cell wall skeleton.
    Ogura T, Hara H, Yokota S, Hosoe S, Kawase I, Kishimoto S, Yamamura Y.
    Cancer Res; 1985 Dec 15; 45(12 Pt 1):6371-5. PubMed ID: 4063987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.